I share evidence-based cancer news, research breakthroughs and survivor stories — no hype, no miracle cures. This feed is for patients, families, clinicians and anyone who believes progress matters. Follow for facts, hope & real science! Curated by @Chris_Geiger #TCSC

November is #LungCancerAwarenessMonth. Swipe to learn the common symptoms of lung cancer. Knowing what’s normal for you can help you spot when something changes. It could be nothing serious, but it’s always worth getting checked. Find out more 👉 nhs.uk/conditions/lung-cance…

Timing could be key to better prostate cancer treatment. Researchers found hormone therapy briefly boosts immune activity in tumours, potentially creating an opportunity for immunotherapy to work more effectively. medicalxpress.com/news/2026-… #ProstateCancer #Immunotherapy #TCSC

Promising kidney cancer results! In a 51-patient trial, alternating bevacizumab and pazopanib achieved median progression-free survival of 24.8 months and overall survival of 63.2 months. medicalxpress.com/news/2026-… #KidneyCancer #CancerResearch #TCSC

The next generation of cancer immunotherapy is taking shape. Researchers are advancing CAR T-cell treatments and other immune therapies for blood cancers and solid tumours, opening new possibilities for patients. cancernetwork.com/view/the-n… #Immunotherapy #CancerResearch #TCSC

Encouraging breast cancer research! A Phase 3 trial found that trastuzumab rezetecan extended median progression-free survival to 16.4 months, compared with 6.8 months on chemotherapy, in advanced HER2-low breast cancer. foxnews.com/health/targeted-… #BreastCancer #Cancer #TCSC

Scientists at UCLA have found a promising way to strengthen cancer-fighting T cells. Activating the p53 protein helped engineered immune cells resist exhaustion and destroy melanoma cells more effectively in laboratory tests. uclahealth.org/news/release/… #Immunotherapy #Cancer #TCSC

A major step forward for personalised cancer vaccines! A Phase 3 trial found that combining an mRNA vaccine with immunotherapy reduced the risk of melanoma returning or death by 42%. pharmaceutical-journal.com/a… #Melanoma #CancerResearch #TCSC

Cancer treatment is more than just chemotherapy. Patients, survivors and their loved ones need support and community — which is exactly why the Lymphoma Research Foundation exists. Learn more about our resources: bit.ly/4hwlfX2

Today on National Lung Health Day, #crypto donors just pushed LCFA past $1M in crypto gifts! We cannot thank you enough. $1M = years of funded lung cancer research. Our grants have drawn 13X return in follow-on research funding. More time for researchers = more time for patients = more Halloweens with their kids, more game nights with friends, more time to spend with people we love. donate.gg/charities/lung-can… @donatedotgg

We’re excited to announce that Alex’s Lemonade Stand Foundation has officially surpassed $400M raised in the fight against childhood cancer! 🎉🎉🎉 It all traces back to our founder, Alex Scott, whose lemonade stand inspired a nationwide grassroots movement that’s made this progress possible since her first stand in 2000: 🍋 Funded more than 1,500 research projects across North America and Europe 🍋 In 1997, when Alex was diagnosed with cancer, survival rates for childhood cancer were just 77%. Today, they’re 85% in the U.S. 🍋 Since our first grant, FDA-approved childhood cancer treatments have increased from 18 to more than 60 today. Thank you to every corporate partner, fundraiser, donor, event attendee and anyone who's helped deliver this incredible progress. We won’t stop until a future free of childhood cancer becomes a reality.

A great gesture from NBA star Brandon Miller! Inspired by his mother’s breast cancer journey, the Charlotte Hornets player provided 500 tickets for breast cancer survivors and their families to enjoy! essentiallysports.com/nba-ac… #BreastCancer #CancerSurvivor #TCSC

Cancer care is about quality of life too. Carle Health has introduced portable scalp-cooling technology to help eligible chemotherapy patients reduce hair loss and preserve a sense of normality during treatment. carle.org/newsroom/community… #Chemotherapy #CancerSupport #TCSC

New hope for prostate cancer research! Scientists at Roswell Park have identified a window after hormone therapy, tumours may be more responsive to immunotherapy, opening the door to better treatment combinations. roswellpark.org/newsroom/202… #ProstateCancer #CancerResearch #TCSC

Major progress in small-cell lung cancer! A Phase 3 trial found tarlatamab plus durvalumab extended median survival to 21.1 months, reducing the risk of death by 58% compared with durvalumab alone. news-medical.net/news/202610… #LungCancer #Immunotherapy #TCSC

A welcome step forward for lymphoma patients! A Cincinnati woman has become the first UC Cancer Center patient to receive CAR-T cell therapy as an outpatient, allowing her to recover in the comfort of her own home. wlwt.com/article/university-… #Lymphoma #CARTCellTherapy #TCSC

Encouraging melanoma breakthrough! A Phase 3 trial found a personalised mRNA cancer vaccine combined with Keytruda reduced the risk of melanoma recurrence or death by 42% compared with Keytruda alone. inc.com/sage-swaby/this-brea… #Melanoma #CancerResearch #TCSC

Cancer survivorship deserves celebrating! Springfield’s Rise Above Cancer Gala honoured people affected by cancer while raising funds for survivor guidance, peer support and practical resources. westernmassnews.com/2026/10/… #CancerSurvivor #CancerSupport #TCSC

Encouraging lung cancer news! A Phase 3 trial found divarasib extended median survival to 17.7 months versus 12 months with existing targeted treatments for KRAS G12C-mutated lung cancer. bioquicknews.com/esmo-2026-n… #LungCancer #CancerResearch #TCSC

Some genuinely encouraging cancer news! A new triple therapy has shrunk tumours in 77% of patients in a small trial involving aggressive head and neck cancer. Early days, but real hope for patients. medium.com/@asecondopinion/t… #CancerResearch #CancerTreatment #Immunotherapy #TCSC

Doctors recommended hospice care. But a clinical trial changed everything. Diagnosed with aggressive leukaemia, father-of-three Ryan Goepel entered remission within weeks and is now two years cancer-free. An extraordinary story! cbsnews.com/news/acute-myelo… #Leukaemia #Cancer #TCSC